Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9939258 | 0.89 | — | — | |
| SCHEMBL17513098 | 0.81 | NFKB1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL2829183 | 0.72 | — | — | |
| SCHEMBL300005 | 0.72 | — | — | |
| Iodide SCHEMBL2827488 | 0.72 | — | — | |
| SCHEMBL294768 | 0.72 | — | — | |
| Bromide SCHEMBL2830437 | 0.72 | — | — | |
| SCHEMBL17332118 | 0.69 | — | — | |
| SCHEMBL301158 | 0.69 | — | — | |
| SCHEMBL2462192 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113996328-B | Catalyst and application thereof in preparation of geraniol by hydrogenating citral | 万华化学集团营养科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-113996328-A | Catalyst and application thereof in preparation of geraniol by hydrogenating citral | 万华化学集团股份有限公司 | 2022-02-01 | — | — | CN | claimed |
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | BHATTACHARYA SHRABANTI (US) | 2025-12-04 | — | — | US | disclosed |
| CN-119998255-A | Catalytic carboxycarbonylation of olefins to form anhydrides | 北卡罗来纳大学教堂山分校 | 2025-05-13 | — | — | CN | disclosed |
| US-20250122269-A1 | SELECTIVE REDUCTION OF ANTIBODIES | ABBVIE INC (US) | 2025-04-17 | — | — | US | disclosed |
| CN-113996328-B | Catalyst and application thereof in preparation of geraniol by hydrogenating citral | 万华化学集团营养科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-110105399-B | Hydrogenation and dehydrogenation catalysts, and methods of making and using the same | 德米特里·顾塞维 | 2022-08-05 | — | — | CN | disclosed |
| US-11305268-B2 | Hydrogenation and dehydrogenation catalyst, and methods of making and using the same | GOUSSEV DMITRI (CA) | 2022-04-19 | — | — | US | disclosed |
| EP-3142992-B2 | PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT | BASF SE (DE) | 2022-02-16 | — | — | EP | disclosed |
| CN-113996328-A | Catalyst and application thereof in preparation of geraniol by hydrogenating citral | 万华化学集团股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20210017222-A1 | SELECTIVE REDUCTION OF ANTIBODIES | ABBVIE INC (US) | 2021-01-21 | — | — | US | disclosed |
| WO-2010069416-A1 | PROCESS FOR PREPARING MONO-CARBOXY-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS BY MEANS OF ALKYLENE OXIDES AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010063342-A1 | METHOD FOR PRODUCING MONO-CARBOXY-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS USING A VINYL ESTER OF A CARBOXYLIC ACID AND THE USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010063344-A1 | METHOD FOR PRODUCING MONO-CARBOXY-FUNCTIONALIZED DIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS USING A VINYL ETHER AND THE USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-06-10 | — | — | WO | disclosed |
| CN-101730656-A | Method for the production of hydrogen from ammonia borane | KANATA CHEMICAL TECHNOLOGIES I | 2010-06-09 | — | — | CN | disclosed |
| WO-2010051887-A1 | METHOD FOR PRODUCING DIALKYLPHOSPHINIC ACIDS AND ESTERS AND SALTS THEREOF BY MEANS OF VINYL COMPOUNDS AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-05-14 | — | — | WO | disclosed |
| WO-2010051883-A1 | METHOD FOR PRODUCING DIALKYLPHOSPHINIC ACIDS AND ESTERS AND SALTS THEREOF BY MEANS OF ALLYL ALCOHOLS/ACROLEINS AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2010-05-14 | — | — | WO | disclosed |
| WO-2010043027-A1 | METHOD FOR PREPARING A METAL CATALYST | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2010-04-22 | — | — | WO | disclosed |
| EP-2167515-A1 | METHOD FOR THE PREPARATION OF AMINOPHOSPHINE LIGANDS AND THEIR USE IN METAL CATALYSTS | Kanata Chemical Technologies Inc. (CA) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008148202-A1 | METHOD FOR THE PREPARATION OF AMINOPHOSPHINE LIGANDS AND THEIR USE IN METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2008-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | CA4, CA12, CA14 | CYP2D6 2558/4885 |
| US-20210017222-A1 | SELECTIVE REDUCTION OF ANTIBODIES | CD2BP2, CD22, CD2 | CYP2D6 1322/4885 |
| US-20250122269-A1 | SELECTIVE REDUCTION OF ANTIBODIES | CD2BP2, CD22, CD2 | CYP2D6 1322/4885 |
| US-11305268-B2 | Hydrogenation and dehydrogenation catalyst, and methods of making and using the same | HSDL2, HSD11B2, HSD11B1 | CYP2D6 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.